scPharmaceuticals Inc (SCPH)
3.49
+0.13
(+3.87%)
USD |
NASDAQ |
Nov 21, 16:00
3.31
-0.18
(-5.16%)
After-Hours: 20:00
scPharmaceuticals Profit Margin (Quarterly): -350.1% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -350.1% |
| June 30, 2024 | -212.2% |
| March 31, 2024 | -231.2% |
| December 31, 2023 | -226.6% |
| Date | Value |
|---|---|
| September 30, 2023 | -411.9% |
| June 30, 2023 | -864.1% |
| March 31, 2023 | -543.4% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-864.1%
Minimum
Jun 2023
-212.2%
Maximum
Jun 2024
-405.6%
Average
-350.1%
Median
Sep 2024
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -265.5% |
| Return on Assets | -85.31% |
| Return on Invested Capital | -111.8% |
| Gross Profit Margin (Quarterly) | 66.98% |
| Operating Margin (Quarterly) | -181.0% |
| Return on Net Operating Assets | -371.5% |